Bory Kea
Director of Clinical Trials · Oregon Health & Science University
Credentials: · · · · ·
History
- Present
Emergency Medicine Research · Oregon Health & Science University
- 2013–2014
Research
Early Convalescent Plasma for High-Risk Outpatients with Covid-19
New England Journal of Medicine · 2021 · 179 citations
PLoS ONE · 2012 · 172 citations
Consensus development for healthcare professionals
Internal and Emergency Medicine · 2015 · First of 2 authors · Corresponding · 68 citations
- DV
9 papers
- BS
8 papers · 1 as a resident
- DB
4 papers
- MR
4 papers
4 papers
3 papers
3 papers
- AC
2 papers · 1 as a resident
Grants
- 2017–2028
The OHSU SIREN Network Enrollment Hub Renewal
National Institute of Neurological Disorders and Stroke · U24
PI · $1.5M · Oregon Health & Science University
- 2021–2027
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.5M · Oregon Health & Science University
- 2017–2020
Optimal Anticoagulation Strategies for Acute Atrial Fibrillation
National Heart, Lung, and Blood Institute · K08
Contact PI · $487.5K · Oregon Health & Science University
Clinical trials
- 2022–2026
Principal investigator · Enrolling by invitation
Oregon Health and Science University
- 2026–2029
The PIONEER Comparative Effectiveness Study - Project 2
Site PI · Not yet recruiting
University of Michigan
- 2026–2029
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
Site PI · Recruiting · Phase 3
University of Virginia